Immunological consequences of splenectomy
Patient education and vaccinations are integral to post-splenectomy prophylactic treatment. Pneumococci and meningococci and H influenza type b are responsible for over 50% of overwhelming sepsis in these patients; therefore, vaccines administration is common. Timing of vaccine administration is a matter of debate. Patient perioperative immunogenicity and decreased immune function are primary concerns. Presplenectomy vaccination is preferred but this is not always an option. Antibodies may not be processed as effectively if vaccines are given too early following surgery so it is general practice to wait 2 weeks post-operatively. The concern with waiting to vaccinate is that it introduces the possibility of the vaccination being missed if the patient is released from the hospital prior to the two week mark or if the patient does not return for the post-operative appointment. Lifelong prophylactic antibiotics are an option but this is highly impractical due to compliance issues and growing antibiotic resistance.
Educating the patient regarding their immunocompromised status and impressing upon them the importance of diligent attention to possible infection impacts morbidity and mortality resulting from infection. Although education alone is not highly reliable, the rapid recognition of possible infection falls to the patient.
Electronic medical records (EMR) assist healthcare providers with the enhanced capability of generating patient reports, treatment guidelines and vaccination reminders. EMR potential for reporting accuracy also increase the likelihood providers will recognize asplenic patients and their particular health needs. Regardless, splenectomy has serious and lifelong immunological implications.
Resources
Recommended Adult Immunization Schedule- United States, 2011; Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report; Feb4, 2011
http://www.cdc.gov/mmwr/PDF/wk/mm6004-Immunization.pdf
Incomplete Care — On the Trail of Flaws in the System; Tejal K. Gandhi, M.D., M.P.H., Gianna Zuccotti, M.D., M.P.H., and Thomas H. Lee, M.D. N Engl J Med 2011; 365:486-488August 11, 2011
http://www.surgicalcriticalcare.net/Guidelines/splenectomy_vaccines.pdf
I found this to be very interesting. I was shocked to learn that while the incidence of OPSS is 0.05% to 2%, according to the CDC, in splenectomized patients, the mortality rate is nearly 50%. With something as severe as OPSS, I wonder how much of the mortality rate is due to lack of patient education or lack of patient action.
ReplyDelete